人类白细胞抗原分子差异与单倍体相合造血干细胞移植结局相关
该研究分析了278例连续单倍体相合造血干细胞移植中,各HLA位点错配表位(ME)负荷对临床结局的影响。宿主抗移植物方向HLA-A及I类位点ME负荷较高与总生存改善相关,HLA-A ME负荷增加与复发风险降低相关;移植物抗宿主方向HLA-B及I类位点ME负荷较高与3-4级急性GVHD风险相关;GVH非允许HLA-DPB1错配与复发保护相关且不增加GVHD。
要点
- 宿主抗移植物方向HLA-A及I类位点ME负荷较高与总生存改善相关。
- HLA-A ME负荷增加与复发风险降低相关。
- 移植物抗宿主方向HLA-B及I类位点ME负荷较高与3-4级急性GVHD风险相关。
核心结论
- 特定HLA位点差异产生的同种异体反应性与移植结局相关。
- 各HLA位点ME分析可能有助于单倍体相合移植的供者选择和风险分层。
研究设计与样本
- 研究纳入278例连续单倍体相合造血干细胞移植患者,分析各HLA位点错配表位负荷对临床结局的影响。
主要发现
- 宿主抗移植物方向HLA-A ME负荷较高与总生存改善相关(HR 0.97,95%CI 0.95-0.99,P=0.003)。
- 宿主抗移植物方向I类位点ME负荷较高与总生存改善相关(HR 0.99,95%CI 0.97-0.99,P=0.045)。
- HLA-A ME负荷增加与复发风险降低相关(亚分布HR 0.95,95%CI 0.92-0.98,P=0.004)。
- 移植物抗宿主方向HLA-B及I类位点ME负荷较高与3-4级急性GVHD风险相关。
- GVH非允许HLA-DPB1错配与复发保护相关(亚分布HR 0.19,95%CI 0.06-0.59,P=0.004),且未伴随GVHD增加。
临床怎么用
- 作者认为,各HLA位点ME分析可能有助于单倍体相合移植的供者选择和风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Haploidentical donors are increasingly used for patients requiring hematopoietic stem cell transplantation (HSCT). Although several factors have been associated with transplant outcomes, the impact of HLA disparity in haploidentical HSCT (haplo-HSCT) remains unclear. We investigated the impact of HLA disparity quantified by mismatched eplets (ME) load of each HLA locus on the clinical outcome of 278 consecutive haploidentical transplants. Here, we demonstrated that the degree of HLA molecular mismatches, at individual HLA loci, may be relevant to clinical outcome in the haplo-HSCT. A significantly better overall survival was associated with higher ME load from HLA-A (hazard ratio [HR], 0.97; 95% confidence interval [CI], 0.95-0.99; P = .003) and class I loci (HR, 0.99; 95% CI, 0.97-0.99; P = .045) in the host-versus-graft direction. The apparent survival advantage of HLA-A ME was primarily attributed to reduced risk in relapse associated with an increase in HLA-A ME load (subdistribution HR, 0.95; 95% CI, 0.92-0.98; P = .004). Furthermore, we have identified an association between the risk of grade 3-4 acute graft-versus-host disease (GVHD) and a higher ME load at HLA-B and class I loci in graft-versus-host (GVH) direction. Additionally, GVH nonpermissive HLA-DPB1 mismatch defined by T-cell epitope grouping was significantly associated with relapse protection (subdistribution HR, 0.19; 95% CI, 0.06-0.59; P = .004) without a concurrent increase in GVHD. These findings indicate that alloreactivity generated by HLA disparity at certain HLA loci is associated with transplant outcomes, and ME analysis of individual HLA loci might assist donor selection and risk stratification in haplo-HSCT.
引用
- Zou J, Ciurea SO, Kongtim P, et al. Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation. Blood Adv. 2020. PMID: 32726398. doi:10.1182/bloodadvances.2019000797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。